A detailed history of Avantax Advisory Services, Inc. transactions in Insmed Inc stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 7,481 shares of INSM stock, worth $498,309. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,481
Previous 6,096 22.72%
Holding current value
$498,309
Previous $408,000 33.82%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$62.0 - $79.01 $85,870 - $109,428
1,385 Added 22.72%
7,481 $546,000
Q2 2024

Aug 09, 2024

BUY
$22.0 - $69.71 $134,112 - $424,952
6,096 New
6,096 $408,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.02B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.